Cedars‑Sinai program on diabetes that follows acute pancreatitis
Cedars Sinai Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium
This program follows people who had acute pancreatitis to find biological and genetic signs that predict who will develop diabetes afterward.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11234961 on NIH RePORTER |
What this research studies
If you had acute pancreatitis, this program follows you over time to see who develops diabetes and why. The team continues enrolling people into the DREAM cohort and runs approved ancillary studies to collect blood, genetic data, and clinical information. Researchers use those samples and health records to identify biomarkers and molecular pathways that link acute pancreatitis to recurrent or chronic pancreatic disease and to diabetes. The goal is to learn patterns that could help predict risk or point to prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates are adults who have had acute pancreatitis, especially those with repeated episodes or new-onset diabetes after pancreatitis.
Not a fit: People without a history of acute pancreatitis or whose diabetes is clearly typical type 2 unrelated to pancreatic injury are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this work could help identify people at high risk for diabetes after pancreatitis earlier and guide steps to prevent or better manage it.
How similar studies have performed: Other cohort and biomarker studies have suggested links between pancreatitis and later diabetes, but linking specific genetics and pathways remains an emerging area that this consortium is expanding.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Goodarzi, Mark — Cedars-Sinai Medical Center
- Study coordinator: Goodarzi, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.